Authorities have raised concerns about counterfeit injection pens falsely labelled as Ozempic, a widely used diabetes drug that gained attention on social media for its perceived weight loss benefits. Ozempic, designed for once-weekly injections to treat type 2 diabetes, has faced increased demand and stock shortages due to its off-label use for weight loss.
The European Medicines Agency (EMA) reported the discovery of fake pre-filled pens in the EU and UK, originating from wholesalers in Austria and Germany. The labels on the counterfeit pens are in German. France’s ANSM medicines authority has urged vigilance throughout the supply chain as a precaution.
Stay connected to UKNIP via Google News
ENJOYED THIS STORY? Choose UKNIP as a 'Preferred Source' on Google News for quick access to the news you value.
